Close Menu

BioReference Laboratories

The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter.

From 2009 to 2012, the laboratory allegedly billed Medicare for testing on hospital inpatients that should have been billed to the hospitals.

News items for in vitro diagnostics industry for the week of August 31, 2020.

GeneDx will provide whole-exome and whole-genome sequencing, among other services, to neonatal intensive care units staffed with Pediatrix-affiliated doctors.

Of the 28 companies in the index, 22 firms saw their stock prices increase, while six firms' share prices decreased.

Lab firms are acquiring equipment and implementing approaches like pooled testing, but it remains unclear if this will be enough to meet a fall surge.

Opko's BioReference Laboratories business processed about 2.2 million COVID-19 molecular tests during the quarter, it said.

The firm will provide information on the seroprevalence of SARS-CoV-2, sharing results with demographic information and analysis in collaboration with the CDC.

Even as the broader lab industry struggles to meet SARS-CoV-2 testing needs, many labs focused on nursing homes are unable to benefit from the demand.

News items for the in vitro diagnostics industry for the week of July 13, 2020.